NUBEQA 300 mg
NUBEQA 300 mg is a medicine authorised by Swissmedic under authorisation number 67521. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 June 2020 and the authorisation is valid without a time limit. ATC code L02BB06 places the medicine in the group Endocrine therapy.
| Authorisation number | 67521 |
|---|---|
| Name | NUBEQA 300 mg |
| Full name | NUBEQA 300 mg, Filmtabletten |
| Authorisation holder | Bayer (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L02BB06 |
| First authorisation | 19 June 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | NUBEQA 300 mg, Filmtabletten | B | 19 June 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 112 | Tablette(n) | L02BB06 | 07.16.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is NUBEQA 300 mg authorised in Switzerland?
Yes. NUBEQA 300 mg is authorised by Swissmedic under authorisation number 67521, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does NUBEQA 300 mg have?
NUBEQA 300 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of NUBEQA 300 mg?
The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.